Novavax, Inc. : Novavax to Present at the Stifel 2015 Healthcare Conference
November 10 2015 - 4:05PM
GAITHERSBURG, Md., Nov. 10, 2015 (GLOBE NEWSWIRE)
-- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced
that Barclay "Buck" Phillips, SVP, Chief Financial Officer and
Treasurer, will present at the Stifel 2015 Healthcare
Conference.
Conference details are as follows:
Date: Tuesday, November 17, 2015
Time: 4:30 p.m. US Eastern Time
Location: New York Palace Hotel, New York City
Live
webcast: http://www.veracast.com/webcasts/stifel/healthcare2015/86112760876.cfm
The webcast and a replay of the presentation will
also be accessible under the "Investors/Events" section of the
Novavax website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Our recombinant nanoparticles
and Matrix-M(TM) adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the Company's website, novavax.com.
Contact: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#1965936
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024